[1]
G. Camargo, W. Favaro, B. Sasaki, I. Reis, Q. Dias, e N. Durán, “New therapeutic approaches for non-muscle invasive bladder cancer (NMIBC): intravesical use of oncotherad biological response modifier and its association with platelet-rich plasma (PRP)”, revpibic, nº 27, p. 1–1, nov. 2019.